The rates and severity of Clostridium difficile infections, including pseudomembranous colitis, have increased markedly. However,there are few effective treatments for refractory or recurrent C. difficile infections and the outcomes are poor. Fecal microbiotatransplantation is becoming increasingly accepted as an effective and safe intervention in patients with recurrent disease,likely due to the restoration of a disrupted microbiome. Cure rates of >90% are being consistently reported from multiple centers. We cured a case of severe refractory C. difficile infection with fecal microbiota transplantation in a patient colonized byvancomycin-resistant enterococcus.